Related Experiment Video
Updated: Feb 25, 2026

Isolation, Characterization, And High Throughput Extracellular Flux Analysis of Mouse Primary Renal Tubular Epithelial Cells
Published on: June 20, 2018
Species Differences in Renal Development and Associated Developmental Nephrotoxicity
1GlaxoSmithKline, King of Prussia, Pennsylvania.
Abstract:
The developing kidney is sensitive to both morphological and functional disturbances during the gestational and postnatal phases of growth and differentiation. Exposure to drugs or chemicals during these critical windows of renal development can result in aplasia, dysplasia, polycystic kidney disease, hydronephrosis, or other features characteristic of nephrotoxicity, including tubule dilation, necrosis, or mineralization. Functional effects can occur without associated morphological abnormalities. Differences in the timing of nephrogenesis and morphologic renal development among species help to explain specific phenotypes of various gestational and postnatal teratogens and nephrotoxins. Functional maturation follows anatomical maturation, but important differences in maximally achieved glomerular filtration rate, concentrating ability and acid-base equilibrium between species makes comparison of these timings critical for accurate and consistent translation of laboratory animal toxicity data to the human clinical experience. Species and age dependent differences in the maturation of kidney transporters, renal xenobiotic metabolism and renal blood flow can have a profound effect on the toxicity profiles of agents and marked differences in the tolerability based on age. Advances in the understanding of the genetics of inherited renal diseases and the underlying cellular and molecular pathogenesis of renal developmental anomalies has helped provide mechanistic understanding of many teratogenic and perinatal nephrotoxic agents. Investigative studies have provided important translational and mechanistic information for assessing human pediatric nephrotoxic potential. Birth Defects Research 109:1243-1256, 2017. © 2017 Wiley Periodicals, Inc.
Insights
The developing kidney is vulnerable to toxins during growth, leading to birth defects and functional impairments. Understanding species-specific developmental differences is crucial for assessing pediatric nephrotoxicity risks.
Area of Science:
- Developmental toxicology
- Nephrology
- Comparative physiology
Background:
- The developing kidney is susceptible to morphological and functional damage during gestation and early life.
- Exposure to xenobiotics can cause congenital anomalies like aplasia, dysplasia, and polycystic kidney disease, or functional deficits.
Purpose of the Study:
- To review the impact of teratogens and nephrotoxins on renal development.
- To highlight species-specific differences in renal development and their implications for toxicity testing.
- To discuss the translational relevance of animal studies to human pediatric nephrotoxicity.
Main Methods:
- Literature review of developmental toxicology and nephrology studies.
- Comparative analysis of renal development timelines and functional maturation across species.
- Examination of genetic and molecular mechanisms underlying renal developmental anomalies.
Main Results:
- Renal development is sensitive to environmental insults, causing structural and functional abnormalities.
- Species-specific differences in nephrogenesis, transporter function, and metabolism influence toxicity outcomes.
- Age-dependent changes in renal physiology impact drug tolerability and toxicity profiles.
Conclusions:
- Understanding species and age-dependent variations in kidney development is essential for accurate risk assessment of environmental agents.
- Advances in genetics and molecular biology enhance the mechanistic understanding of developmental nephrotoxicity.
- Investigative studies provide critical data for evaluating pediatric nephrotoxic potential in humans.
Related Concept Videos
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Nephrons
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology
Drug Toxicity: Risk factors

